Recombinant EGFR (Cetuximab Biosimilar) antibody

Catalog No. ABIN7597586

The Chimeric Chimeric anti-EGFR (Cetuximab Biosimilar) antibody (ABIN7597586) specifically detects EGFR (Cetuximab Biosimilar). The antibody is reactive with Human samples.

Quick Overview for Recombinant EGFR (Cetuximab Biosimilar) antibody (ABIN7597586)

Target: EGFR (Cetuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: This EGFR (Cetuximab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-EGFR (Cetuximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Cetuximab Biosimilar Antibody

Specificity: HER1, Receptor tyrosine-protein kinase erbB-1, Proto-oncogene c-ErbB-1, Epidermal growth factor receptor, EGFR, ERBB1, ERBB

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 5.33 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for EGFR (Cetuximab Biosimilar)

Target: EGFR (Cetuximab Biosimilar)

Alternative Name: Cetuximab Biosimilar

Target Type: Biosimilar

Background: HER1, Receptor tyrosine-protein kinase erbB-1, Proto-oncogene c-ErbB-1, Epidermal growth factor receptor, EGFR, ERBB1, ERBB

UniProt: P00533

CAS-No: 205923-56-4